Sulfonamides

Details for Australian Patent Application No. 2006283208 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-B-2006283208

PCT Pub. Number WO2007/024860

Priority 60/710,537 22.08.05 US; 11/465,847 21.08.06 US

Filing date 22 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 1 September 2011

International Classifications

C07C 311/06 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/195 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07C 311/19 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/024860 Priority application(s): WO2007/024860

24 January 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Allergan Inc., Application No. 2006283208, Under INID (71), correct the applicant name to Allergan, Inc.

1 September 2011 Application Accepted

  Published as AU-B-2006283208

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283211-Methods and formulations for modulating Lyn kinase activity and treating related disorders

2006283207-Process for preparing beta-lactamase inhibitors